ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1601

Prevalence of Peripheral Neuropathy and Its Electrophysiological Types in Patients with Systemic Lupus Erythematosus

Cynthia Matilda Wendo1, George Oyoo 1, Thomas Otieno Kwasa 1, Marybeth Maritim 1, Sybil Nakitare 2 and Judith Kwasa 1, 1University of Nairobi, Nairobi, Kenya, 2Kenyatta National Hospital, Nairobi, Kenya

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: neuropathy, neuropsychiatric and SLICC, Peripheral, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Clinical Poster II: Comorbidities

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Peripheral neuropathy (PN), one of the neuropsychiatric syndromes of SLE, occurs in 2% to 36% of patients. It has been associated with high disease activity indices and poor quality of life scores. The aim of this study was to determine the prevalence of peripheral neuropathy using clinical evaluation and Nerve Conduction Studies (NCS), to describe its electrophysiological types using NCS; and to correlate quality of life with presence of peripheral neuropathy among SLE patients

Methods: This was a crossectional study of SLE patients attending Rheumatology outpatient clinic.  Fourty eight patients with a diagnosis of SLE as per the 2012 Systemic Lupus International Collaborating Clinics (SLICC) criteria who were 18 years and above were consecutively selected for the study. Patients were excluded if they were Amputees, had history of traumatic involvement affecting the nerves, had foot ulcerations, those with other known causes of peripheral neuropathy such as mixed connective tissues disease, diabetes mellitus, and history of heavy alcohol consumption, chronic renal failure and pernicious anemia.  Socio-demographic data and clinical information were obtained from the patient’s medical records. Structured history and clinical examination was performed on all patients. All patients had NCS carried out and at least 5 nerves were tested: the median, the ulnar, the peroneal, the sural and the Tibial. Lupus quality of life questionnaire was administered to all patients.

Results: Prevalence of PN was suggestive in 29 out of 48 patients (60.4%). Of these 27.1% were symptomatic for peripheral neuropathy and had abnormal nerve conduction studies while 25 % were symptomatic for peripheral neuropathy and had normal nerve conduction studies. The other 8.3 % had abnormal nerve conduction studies despite being asymptomatic (figure 1). Numbness was the most common symptom complaint in 41.7% of patients. The most common nerve conduction abnormality was demyelination 9(52.94%). However excluding 5 patients found to have carpal tunnel syndrome, then demyelination was 4(23.52%), While axonopathy was found in 5(29.41%) of the patients. Motor neuropathy was the most prevalent nerve conduction syndromes in 9(52.94%) patients. There was a significant correlation between the presence of peripheral neuropathy with lower quality of life scores involving the domains of physical health (p=< 0.001), pain (p=0.012), planning (p=0.003), and fatigue (p=0.005).

Conclusion: There is a high prevalence of peripheral neuropathy among SLE patients, with variable clinical and electrophysiologic presentation. Quality of life is scores are lower in affected patients


figure 1-converted


Disclosure: C. Wendo, None; G. Oyoo, None; T. Otieno Kwasa, None; M. Maritim, None; S. Nakitare, None; J. Kwasa, None.

To cite this abstract in AMA style:

Wendo C, Oyoo G, Otieno Kwasa T, Maritim M, Nakitare S, Kwasa J. Prevalence of Peripheral Neuropathy and Its Electrophysiological Types in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-peripheral-neuropathy-and-its-electrophysiological-types-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-peripheral-neuropathy-and-its-electrophysiological-types-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology